DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
McDermott DF, Lee J-L, Bjarnason GA. et al.
Open-label, single-arm phase ii study of pembrolizumab monotherapy as first-line therapy in patients with advanced clear cell renal cell carcinoma.
J Clin Oncol 2021;
39 (09) 1020-1028
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.